The contribution of demyelination to axonal loss in multiple sclerosis

Brain

Volumn 129, Issue 6, 2006, Pages 1507-1516

  DeLuca, G C ^a   Williams, K ^a   Evangelou, N ^c   Ebers, G C ^a   Esiri, M M ^a,b,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Axon; Axonal degeneration; Demyelination; Multiple sclerosis; Neuropathology

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CORTEX; BRAIN STEM; CADAVER; CONTROLLED STUDY; CORRELATION FUNCTION; DEMYELINATION; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PYRAMIDAL TRACT; SPINAL CORD; WHITE MATTER; BRAIN; DEMYELINATING DISEASE; MIDDLE AGED; MYELIN SHEATH; NERVE FIBER; PATHOLOGY; REGRESSION ANALYSIS; TELENCEPHALON;

ADULT; AGED; AGED, 80 AND OVER; AXONS; BRAIN; BRAIN STEM; DEMYELINATING DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; PYRAMIDAL TRACTS; REGRESSION ANALYSIS; SPINAL CORD; TELENCEPHALON;

EID: 33745115644     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl074     Document Type: Article

References (45)

1. Behan WM, Maia M. Strumpell's familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 1974; 37: 8-20.
2. Bergers E, Bot JC, De Groot CJ, Polman CH, Lycklama a Nijeholt GJ, Castelijns JA, et al. Axonal damage in the spinal cord of multiple sclerosis patients occurs largely independent of T2 MRI lesions. Neurology 2002; 59: 1766-71.
3. Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD. Axonal loss in normal-appearing white matter in a patient with acute multiple sclerosis. Neurology 2001; 57: 1248-52.
4. Coles AJ, Wing MG, Molyneux P, Paolillo A, Davie CM, Hale G, et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999; 46: 296-304.
5. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430-8.
6. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126: 770-82.
7. Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995; 118: 1583-92.
8. DeLuca GC, Ebers GC, Esiri MM. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 2004a; 127: 1009-18.
9. DeLuca GC, Ebers GC, Esiri MM. The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol 2004b; 30: 576-84.
10. Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000a; 47: 391-5.
11. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2000b; 123: 1845-9.
12. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001; 124: 1813-20.
13. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9.
14. Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995; 45: 255-60.
15. Fog T. Topographical distribution of plaques in the spinal cord in multiple sclerosis. Arch Neurol Psychiat 1950; 63: 382-414.
16. Ganter P, Prince C, Esiri MM. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 1999; 25: 459-67.
17. Gasperini C, Paolillo A, Giugni E, Galgani S, Bagnato F, Mainero C, et al. MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a. Mult Scler 2002; 8: 119-23.
18. Hemmer B, Glocker FX, Schumacher M, Deuschl G, Lucking CH. Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings, [see comment]. J Neurol Neurosurg Psychiatry 1998; 65: 822-7.
19. Horsfield MA, Filippi M. Spinal cord atrophy and disability in multiple sclerosis over four years. J Neurol Neurosurg Psychiatry 2003; 74: 1014-5.
20. Howard V, Reed MG. Royal Microscopical Society (Great Britain). Unbiased stereology: three dimensional measurement in microscopy. Oxford: BIOS Scientific in association with the Royal Microscopical Society; 1998.
21. Iannucci G, Minicucci L, Rodegher M, Sormani MP, Comi G, Filippi M. Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T(1), T(2) and MT histograms. J Neurol Sci 1999; 171: 121-9.
22. Ikuta F, Zimmerman HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 1976; 26: 26-8.
23. Jitpimolmard S, Small J, King RH, Geddes J, Misra P, McLaughlin J, et al. The sensory neuropathy of Friedreich's ataxia: an autopsy study of a case with prolonged survival. Acta Neuropathol (Berl) 1993; 86: 29-35.
24. Kremenchutzky M, Cottrell D, Rice G, Hader W, Baskerville J, Koopman W, et al. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain 1999; 122: 1941-50.
25. Kremenchutzky M, Rice GPA, Baskerville J, Wingerchuk DM, Ebers GC. The natural history of multiple sclerosis: a geographically based study IX. Observations on the progressive phase of the disease. Brain 2006; 129: 584-94.
26. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-12.
27. Lin X, Tench CR, Turner B, Blumhardt LD, Constantinescu CS. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry 2003; 74: 1090-4.
28. Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996; 119: 701-8.
29. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000; 123: 308-17.
30. Lumsden CE. The immunogenesis of the multiple sclerosis plaque. Brain Research 1971; 28: 365-90.
31. Mainero C, De Stefano N, Iannucci G, Sormani MP, Guidi L, Federico A, et al. Correlates of multiple sclerosis disability assessed in vivo using aggregates of MR quantities. Neurology 2001; 56: 1331-4.
32. McAlpine D, Lumsden CE, Acheson ED. Multiple sclerosis: a reappraisal. Edinburgh: Churchill Livingstone; 1972.
33. McGavern DB, Murray PD, Rivera-Quinones C, Schmelzer JD, Low PA, Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain 2000; 123: 519-31.
34. Oppenheimer DR. The cervical cord in multiple sclerosis. Neuropathol Appl Neurobiol 1978; 4: 151-62.
35. Ozawa K, Suchanek G, Breitschopf H, Bruck W, Budka H, Jellinger K, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994; 117: 1311-22.
36. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, et al. Disability profile of multiple sclerosis did not change over 10 years in a population-based prevalence cohort. Neurology 2004; 62: 601-6.
37. Poser CM. Pathogenesis of multiple sclerosis. A critical reappraisal. Acta Neuropathol (Berl) 1986; 71: 1-10.
38. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993; 33: 137-51.
39. Said G, Marion MH, Selva J, Jamet C. Hypotrophic and dying-back nerve fibers in Friedreich's ataxia. Neurology 1986; 36: 1292-9.
40. Silber E, Sharief MK. Axonal degeneration in the pathogenesis of multiple sclerosis. J Neurol Sci 1999; 170: 11-8.
41. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.
42. Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999; 12: 295-302.
43. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989a; 112: 133-46.
44. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989b; 112: 1419-28.
45. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991; 114: 1045-56.